Chloraprep One-step is a drug owned by Becton Dickinson And Co. It is protected by 4 US drug patents filed in 2013 out of which all have expired. Based on its patents and exclusivities, its generic launch date is estimated to be Jan 31, 2024. Details of Chloraprep One-step's patents and their expiration are given in the table below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| These drug patents focus on the other aspects of the drug like dosage, mode of administration (oral, tablet, capsules, liquids etc). | |||
| US6991394 | Liquid applicator with a mechanism for fracturing multiple ampoules |
Jan, 2024
(10 months ago) |
Expired
|
| US7182536 | Antiseptic applicator with mechanism for fracturing multiple ampoules |
Dec, 2023
(11 months ago) |
Expired
|
| US6536975 | Liquid applicator with opposed wings |
Nov, 2020
(4 years ago) |
Expired
|
| US5690958 | Unit dose chlorhexadine gluconate(CHG) applicator having extended CHG shelf life |
Sep, 2016
(8 years ago) |
Expired
|
A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Chloraprep One-step's patents.
Latest Legal Activities on Chloraprep One-step's Patents
Given below is the list of recent legal activities going on the following patents of Chloraprep One-step.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 12th Year, Large Entity | 20 Jul, 2018 | US7182536 |
| Entity Status Set To Undiscounted (Initial Default Setting or Status Change) | 26 Aug, 2010 | US7182536 |
| Change in Power of Attorney (May Include Associate POA) Critical | 24 Sep, 2009 | US6991394 |
| Change in Power of Attorney (May Include Associate POA) Critical | 24 Sep, 2009 | US7182536 |
| Correspondence Address Change Critical | 22 Sep, 2009 | US7182536 |
| Correspondence Address Change Critical | 22 Sep, 2009 | US6991394 |
| Entity Status Set To Undiscounted (Initial Default Setting or Status Change) | 11 Aug, 2009 | US6991394 |
| Recordation of Patent Grant Mailed Critical | 27 Feb, 2007 | US7182536 |
| Patent Issue Date Used in PTA Calculation Critical | 27 Feb, 2007 | US7182536 |
| Issue Notification Mailed Critical | 07 Feb, 2007 | US7182536 |
US patents provide insights into the exclusivity only within the United States, but Chloraprep One-step is protected by patents in multiple countries. Understanding the full scope of patent protection is crucial in strategizing market entry. By looking at the broader patent landscape, you can identify markets with weaker patent protection which could be ideal generic entry points. The following section offers details on Chloraprep One-step's family patents as well as insights into ongoing legal events on those patents.
Chloraprep One-step's Family Patents
Explore Our Curated Drug Screens
Generic Launch
Generic Release Date:
Chloraprep One-step's generic launch date based on the expiry of its last outstanding patent is estimated to be Jan 31, 2024 (This date is subject to change depending upon the patent filing activities by the drug owner or exclusivity additions to its drug application)
Chloraprep One-step Generics:
There are no approved generic versions for Chloraprep One-step as of now.
Alternative Brands for Chloraprep One-step
There are several other brand drugs using the same active ingredient (Chlorhexidine Gluconate; Isopropyl Alcohol) as Chloraprep One-step. Given below is the list of those companies and their brand drugs, to help you identify new opportunities, assess competitors, and plan your market strategies more effectively.
| Drug Owner | Drug Name | |||
|---|---|---|---|---|
| 3m Health Care |
| |||
| Becton Dickinson Co |
| |||
| Prof Dspls |
|
About Chloraprep One-step
Chloraprep One-Step is a drug owned by Becton Dickinson And Co. Chloraprep One-Step uses Chlorhexidine Gluconate; Isopropyl Alcohol as an active ingredient. Chloraprep One-Step was launched by Becton Dickinson Co in 2000.
Approval Date:
Chloraprep One-step was approved by FDA for market use on 14 July, 2000.
Active Ingredient:
Chloraprep One-step uses Chlorhexidine Gluconate; Isopropyl Alcohol as the active ingredient. Check out other Drugs and Companies using Chlorhexidine Gluconate; Isopropyl Alcohol ingredient
Dosage:
Chloraprep One-step is available in sponge form for topical use. Given below is detailed information on Dosage -
| Strength | Dosage Form | Availability | Application Pathway |
|---|---|---|---|
| 2%;70% (26ML) | SPONGE | Over the counter | TOPICAL |
| 2%;70% (10.5ML) | SPONGE | Over the counter | TOPICAL |
| 2%;70% (3ML) | SPONGE | Over the counter | TOPICAL |